SCHEMBL11746332

SCHEMBL11746332

CC(C)N(CCO)c1nnc(-c2ccc([S+](C)[O-])cc2)c(-c2ccc([S+](C)[O-])cc2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11750097 0.86 — —
SCHEMBL11741002 0.84 SLC29A1 (0.35) —
SCHEMBL11745513 0.84 CA12 (0.33) —
SCHEMBL11745266 0.81 APP (0.34) —
SCHEMBL11747846 0.81 SLC29A1 (0.32) —
SCHEMBL11747477 0.80 CYP1A2 (0.30) —
SCHEMBL11744957 0.79 RAD51 (0.30) —
SCHEMBL11748724 0.79 RAD51 (0.30) —
SCHEMBL11743524 0.78 — —
SCHEMBL11743535 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4008232-A ANTIINFLAMMATORY ELI LILLY AND COMPANY (US) 1977-02-15 — — US disclosed
US-3948894-A ANTIINFLAMMATORY ELI LILLY AND COMPANY (US) 1976-04-06 — — US disclosed
Send feedback